MedTrace Logo

Use of ΔIVC for Early Diagnosis of AHF in AECOPD

NCT05327374 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 401

Last updated 2023-05-16

No results posted yet for this study

Summary

Acute Heart failure (AHF) is a common cause of acute exacerbation of chronic obstructive pulmonary disease (AECOPD).

This association is frequently underestimated with regard to the difficulty of clinical diagnosis.

The investigators expect that the application of the inferior vena cava collapsibility index (ΔIVC)could be useful in this issue.

Conditions

  • Acute Decompensated Heart Failure
  • COPD Exacerbation

Interventions

DIAGNOSTIC_TEST

calculation of the inferior vena cava collapsibility index

the ΔIVC was calculated by the emergency physician who was blinded from the patient's medical history using the formula ((IVCmax-IVCmin)/IVCmax) X100.A cutoff of 15% was used to define the presence(\<15%) or absence(\>15%) of heart failure

Sponsors & Collaborators

  • University of Monastir

    lead OTHER

Principal Investigators

  • Nouira Semir, Professor · University of Monastir

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-01
Primary Completion
2022-11-30
Completion
2023-01-31

Countries

  • Tunisia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05327374 on ClinicalTrials.gov